#15,839
On Saturday, Feb 27th, the FDA Issued An Emergency Use Authorization for A Third COVID-19 Vaccine, manufactured by Johnson & Johnson. Unlike the Pfizer and Moderna vaccines, the Janssen vaccine has the advantage of only requiring a single dose.
These presentations are often technical, and are of greatest interest to clinicians and healthcare providers, but also may be of interest to the general public.With this new option expected to be available within a week or so, the CDC will hold a COCA Call on Tuesday afternoon on this newest vaccine.
If you are unable to attend the live presentation, these webinars are always archived and available for later viewing at this LINK.
What Clinicians Need to Know About Johnson & Johnson’s Janssen COVID-19 Vaccine
Overview
This COCA Call will give clinicians an overview of the J&J Janssen COVID-19 vaccine. Clinicians will learn about vaccine characteristics and administration, vaccinating special populations, and contraindications. They will also get answers to a number of clinical questions CDC has received about this new vaccine.
Presenters
Sarah Mbaeyi, MD, MPH
CDR, U.S. Public Health Service
Medical Officer
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Sara Oliver, MD
LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention
Kathleen Dooling, MD, MPH
Medical Officer
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention
Call Materials
None at this time
Call Details
When:
Tuesday, March 2, 2021,
2:00 PM – 3:00 PM ET
Webinar Link:
https://www.zoomgov.com/j/1603748312?pwd=anlmUURkSEtmdzBLSmNOV0pJSzZUQT09external icon
Passcode: 893944
Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 551 285 1373
or +1 669 216 1590
International numbersexternal icon
iPhone one-tap:
US: +16692545252,,1603748312#,,,,*893944# or +16468287666,,1603748312#,,,,*893944#
Webinar ID: 160 374 8312Add to Calendar